EAACI Congress 2025

Back
13 - 16 June 2025 Glasgow, United Kingdom

TPS39 - Dermatology 03

Saturday 14 Jun, 12:00 PM - 13:00 PM Glasgow, United Kingdom
Poster Zone Thematic Poster Session
D2.319
Advancing Diagnosis and Management of Hereditary Angioedema in Brazil: Insights from the first 704 patients of a Multicenter Registry
D2.315
Clinical features and Progress of Diagnosis and Therapy of Hereditary Angioedema in China: A Systemic Review of Published Cases
D2.309
Descriptive Study of Chronic Urticaria Under Treatment with Omalizumab: Our Experience
D2.310
Dysregulation of barrier function and distribution of nerve cells in a mouse model of atopic dermatitis
D2.323
Higher neonatal urinary phthalate are associated with the development of infantile atopic dermatitis
D2.312
Impact of metabolic disorders on immune dysregulation in psoriasis and atopic dermatitis
D2.313
Importance of non-itchy erythema marginatum as a prodromal symptom of hereditary angioedema attacks
D2.314
Late Presentation of Cutaneous Chronic Graft Versus Host Disease – A Case Report
D2.324
Psychological Burden Associated with Injectable HAE On-Demand Treatments: A Patient and Caregiver Interview Study
D2.322
Quality of life of families with children suffering from chronic urticaria
D2.311
Real World Web Survey on the Burden of Urticaria
D2.316
The role of Tumor necrosis factor ligand superfamily member 15 in Atopic dermatitis
D2.317
The role of sirtuin 2 (SIRT2) in atopic dermatitis
D2.318
Triggers and prodromal indicators of angioedema attacks in hereditary angioedema patients

Chairs

Speakers